DMED — Diagnamed Holdings Balance Sheet
0.000.00%
Last trade - 00:00- CA$9.28m
- CA$9.02m
- 13
- 22
- 58
- 20
Annual balance sheet for Diagnamed Holdings, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 2.36 | 1.57 | 0.607 | 0.162 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.032 | 0.045 | 0.055 | 0.032 |
| Prepaid Expenses | ||||
| Total Current Assets | 2.39 | 1.62 | 0.662 | 0.202 |
| Total Assets | 2.39 | 1.62 | 0.662 | 0.202 |
| Payable / Accrued | ||||
| Notes Payable / Short Term Debt | ||||
| Total Current Liabilities | 0.15 | 0.37 | 0.426 | 0.467 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.15 | 0.37 | 0.426 | 0.467 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 2.24 | 1.25 | 0.236 | -0.265 |
| Total Liabilities & Shareholders' Equity | 2.39 | 1.62 | 0.662 | 0.202 |
| Total Common Shares Outstanding |